When was IQVIA founded?

IQVIA was founded in 1982 and raised its 1st funding round 24 years after it was founded.

Where is IQVIA located?

IQVIA is headquartered in Durham, United States. It is registered at 2a Rothwell Avenue, Rosedale, Auckland, 0632, New Zealand.

How many employees does IQVIA have?

As of Apr 30, 2026, the latest employee count at IQVIA is 78101.

Is IQVIA a funded company?

IQVIA is a funded company, having raised a total of $1.74M across 10 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Apr 01, 2006.

When was the latest funding round of IQVIA?

IQVIA's latest funding was a $***** Grant (prize money) round on Dec 01, 2023, with participation from 1 investor.

What is the annual revenue of IQVIA?

Annual revenue of IQVIA is more than $1B as on Dec 31, 2025

Where does IQVIA rank among its competitors?

IQVIA ranks 3rd amongst 664 active competitors, of which 119 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Verily, which secured $300M in Mar, 2026.

Who are the top competitors of IQVIA?

IQVIA's top competitors include Medidata, Verily and Innovaccer. Among them, Verily secured the most recent funding round in March, 2026.

IQVIA - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of clinical research and commercialization solutions for healthcare. It offers services across research and development, real-world evidence generation, and commercialization, along with safety and regulatory compliance solutions. The company caters to life science segments, including consumer health, emerging biopharma, generics, medtech, and pharmaceutical manufacturers. It also serves healthcare segments such as information partner services, financial institutions, global health organizations, government entities, patient associations, payers, and providers. It provides technologies and products for clinical, commercial, compliance, safety, and real world applications.

Website: iqvia.com
Social
Phone Number: +1 **********
Registered Address: 2a Rothwell Avenue, Rosedale, Auckland, 0632, New Zealand

Key Metrics

Founded Year

1982

Location

Durham, United States

Stage

Public

Total Funding

$1.74M in 10 rounds

Latest Funding Round

Grant (prize money), Dec 01, 2023, $*****

Investors

Leonard Green and Partners & 13 more

Ranked

3^rd among 664 active competitors

Annual Revenue

$1B+ as on Dec 31, 2025

Employee Count

78,101 as on Apr 30, 2026

Investment & Acquisitions

Whiz & 24 more

Similar Companies

Medidata & 832 more

Exit Details

Public

View IQVIA's full profile

IQVIA is associated with 10 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
IQVIA ANALYTICS SERVICES PRIVATE LIMITED CIN: U74140KA2003PTC032950 , India, Active	Dec 02, 2003	₹1,000+ Cr (As on Mar 31, 2025)	5451 (As on Jan 31, 2024)
IQVIA SOLUTIONS (NZ) LIMITED CIN: 84002 , New Zealand, Active	Dec 21, 1971	-	-
Iqvia Holdings Inc. CIN: 1478242 , United States, Active		$1B+ (As on Dec 31, 2025)	-	-
IQVIA RDS (INDIA) PRIVATE LIMITED CIN: U74909KA2002PTC107115 , India, Active	Nov 21, 2002	₹1,000+ Cr (As on Mar 31, 2025)	15387 (As on Sep 30, 2024)
CZE-Solutions s.r.o. CIN: 19305427 , Czech Republic, Active	May 03, 2023	-	-
Global Trend Czechia s.r.o. CIN: 19809336 , Czech Republic, Active	Oct 10, 2023	-	-
Ardentia Ltd CIN: 11175573 , United Kingdom, Active	Jan 28, 2018	-	-
CZECH REAL, s.r.o. CIN: 26419386 , Czech Republic, Active	Dec 18, 2000	-	-
QUINTILES IMS HOLDINGS, INC. CIN: 1478242 , United States, Active		$1B+ (As on Dec 31, 2024)	87000 (As on Dec 31, 2023)	-
IQVIA HOLDINGS INC. CIN: 6171073 , United States, Active	Oct 03, 2016	-	88000 (As on Dec 31, 2024)	-

IQVIA got listed on May 10, 2013.

Click here to take a look at IQVIA's IPO in detail

IQVIA has raised a total funding of $1.74M over 10 rounds. Its first funding round was on Apr 01, 2006. Its latest funding round was a Grant (prize money) round on Dec 01, 2023 for $*****. 1 investor participated in its latest round. IQVIA has 14 institutional investors.

Here is the list of recent funding rounds of IQVIA:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 01, 2023	2202333	Grant (prize money)	7808927	5867785	2871540	8647022
Dec 11, 2021	6849456	Grant (prize money)	7324377	3611172	7267023	Europa
Dec 10, 2021	4032175	Grant (prize money)	2055287	2841458	1459385	Europa

Access funding benchmarks and valuations. Sign up today!

View details of IQVIA's funding rounds and investors

The founders of IQVIA are Dennis Gillings and James Thomas. Ari Bousbib is the CEO of IQVIA.

Here are the details of IQVIA's key team members:

Dennis Gillings: Founder of IQVIA and founder of 2 other companies, Centrix and GHO Capital Partners.
James Thomas: Founder, and Head Of Development, Tech Support, and Technical Writing of IQVIA.
Tom Pike: ex-CEO of IQVIA.
Ari Bousbib: CEO of IQVIA.
Contact Info: 3 email addresses

View details of IQVIA's Founder profiles and Board Members

IQVIA's employee count trend

IQVIA has 78,101 employees as of Apr 26. Here is IQVIA's employee count trend over the years:

Uncover IQVIA's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of IQVIA include Medidata, Verily and Innovaccer. Here is the list of Top 10 competitors of IQVIA, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	82/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Aisling Capital ... & 12 others	80/100
4th	Innovaccer 2014, San Francisco (United States), Series F	Developer of healthcare data platforms and artificial intelligence agent software	$675M	WestBridge Capital, Tiger Global Management ... & 36 others	78/100
5th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	T. Rowe Price, New Enterprise Associates ... & 11 others	77/100
6th	Hublo 2013, Montreuil (France), Series C	Workforce management and staffing platform designed for healthcare and social care institutions	$97.9M	Acton Capital, Y Combinator & 5 others	72/100
7th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
8th	Manifold AI 2016, Oakland (United States), Series B	Provider of an AI platform for life sciences research and development	$40M	TQ Ventures, Reach Capital & 13 others	71/100
9th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	70/100
10th	AVIA 2003, Chicago (United States), Series B	Digital business management and networking platform for the healthcare industry	$50M	Providence Health & Services, MemorialCare Innovation Fund ... & 20 others	68/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on IQVIA's competitors? Click here to see the top ones

IQVIA has made 5 investments in companies including Adiuvo Diagnostics and BC Platforms. IQVIA has also acquired 20 companies including Whiz and Lasso.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
May 2025	Acquisition	Whiz	2017	New York City (United States)
Oct 26, 2022	Acquisition	Lasso	2019	Austin (United States)
Aug 12, 2022	Acquisition	Pharmaspectra	2005	London (United Kingdom)